Effect of Variability in Anemia Management on Hemoglobin Outcomes in ESRD
Authors:
- Eduardo LacsonELEduardo Lacson
- Norma OfsthunNONorma Ofsthun
- J.Michael LazarusJLJ.Michael Lazarus
- 1 January 2003
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 41 (1) , 111-124
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Increasing the Hematocrit Has a Beneficial Effect on Quality of Life and Is Safe in Selected Hemodialysis PatientsJournal of the American Society of Nephrology, 2000
- The Impact of Recombinant Human Erythropoeitin on Exercise Capacity in Hemodialysis PatientsAdvances in Renal Replacement Therapy, 1994
- rHuEPO treatment improves brain and cognitive function of anemic dialysis patientsKidney International, 1991
- Exercise in Hemodialysis Patients after Treatment with Recombinant Human ErythropoietinNephron, 1991
- Improvement of brain function in hemodialysis patients treated with erythropoietinKidney International, 1990
- Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.BMJ, 1990
- Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietinThe Lancet, 1990
- Improved Sexual Function During Recombinant Human Erythropoietin TherapyNephrology Dialysis Transplantation, 1990
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Working capacity is increased following recombinant human erythropoietin treatmentKidney International, 1988